Clinical Trial: Open to patients diagnosed with symptomatic orthostatic hypotension due to Parkinson's disease, multiple system atrophy, or pure autonomic failure. This multiple-center, randomized, two-part, single- and double-blind study will be conducted in male and female subjects with neurogenic orthostatic hypotension (nOH) to evaluate the effect of TD-9855 in improving symptoms of orthostatic intolerance.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff via the contacts provided at the clinical trials website: https://clinicaltrials.gov/ct2/show/NCT02705755